Nasdaq Stockholm decides to officially list 1 bond loan issued by BNP Paribas Arbitrage Issuance B.V with effect from 2016-11-09. The instrument will be listed on STO Structured Products. Please find instrument identifiers in the attached document. Nasdaq Stockholm AB, Issuer Surveillance, dl-ilasto@nasdaq.com, +46 8 405 7050
Listing of bond loan issued by BNP Paribas Arbitrage
Top 10 Most Recent News Articles
Ajman Spotlights Tourism at Arabian Travel Market 2026
Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...
Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse
Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...
Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past
Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...
Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights
Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...
Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight
Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...
Continue Reading
U.S. Green Beret's Mission: Clearing Landmines in Ukraine
The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...
Continue Reading
USPS Honors 150 Years of the U.S. Coast Guard Academy
Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...
Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know
Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...
Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future
Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...
Continue Reading
Trial Disappointment: No Significant Gains in NSCLC
Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...
Continue ReadingTop 5 Most Recently Viewed Articles
Transforming Industries: The Future of AI with Dahua's Xinghan
Dahua Technology Unveils Innovative AI Solutions Dahua Technology is at the forefront of video-centric AI and IoT solutions. The company has recently introduced the powerful Xinghan Large-scale AI Models, which represent a significant advancement in AI technology. These models are designed to tackle complex challenges in various sectors by integrating large-scale visual...
Continue Reading
Innovations in Payment Technologies: A Deep Dive Discussion
An Insightful Overview of Emerging Payment Technologies Exploring the U.S. Payments Forum's Recent Findings The U.S. Payments Forum recently conducted a comprehensive summer market snapshot, gathering insights from prominent payment organizations during an extensive virtual educational series. This dynamic session attracted a broad spectrum of payment industry...
Continue Reading
Private Sector Employment Rises Despite Slower Momentum
U.S. Business Activity Hits 27-Month High in July July's 27-month high in U.S. business activity suggests strong economic momentum. Rising from 54.8 in June to 55.0, the flash U.S. Composite PMI Output Index from S&P Global Since April 2022 this is the highest level. Tracking both manufacturing and services, the index has a reading above 50 suggesting growth. Driven by...
Continue Reading
Philips Advances Patient Care with Pioneering PAD Treatment
Philips Leads the Way in Peripheral Artery Disease Treatment Philips has recently achieved a remarkable milestone in the realm of healthcare with the enrollment of the first patient in a groundbreaking clinical trial in the United States. This innovative trial focuses on an integrated device that utilizes cutting-edge laser technology to treat peripheral artery disease...
Continue Reading
HTX's Innovative Funds Bonus Trial Program Drives Crypto Growth
HTX Introduces a Game-Changing Funds Bonus Trial Program HTX has officially launched its New Funds Bonus Trial Program, an innovative initiative aimed at rewarding users for their net new funds deposited on the platform. This groundbreaking program represents a shift from conventional commission models, focusing on creating lasting partnerships between the platform and...
Continue Reading